Physicists Receive Patent for Improved Cancer Therapy Device

Four physicists at the U.S. Department of Energy's Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a “medical synchrotron” capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue. The new device would be more precise and less costly than existing proton-therapy systems, potentially increasing the availability and benefits of this treatment for cancer patients worldwide. The Brookhaven scientists are now seeking industrial partners to license and commercialize the technology.

If you want to include this story in your blog, copy and paste this formatted text: